Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Alkermes outlined plans to move its NT1 drug candidate, alixorexton, into phase 3 after posting results from the midstage ...

Hernán’s appointment comes at a pivotal moment as Takeda intensifies its focus on advancing sustainable, value-based ...

Volleyball coach and influencer Chijo Takeda teamed up with Ikaika Ohana Volleyball to host clinics in Richland over the ...

Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHub and HyHub ...

With every detail, the designers, Ishka Designs, created a portrait of their client in this New York apartment.

Takeda is making waves in data and artificial intelligence (AI) with Informatica and AWS: 90% of data moved to the cloud, 40% higher productivity and millions saved in IT overhead. Discover how ...

KalVista Pharmaceuticals faces a shrinking HAE market, tough competition, and launch uncertainty despite FDA approval. Read ...

The LPGA had an off week between events in France and Scotland, giving players the rare chance to unplug from the tour grind ...

Takeda Pharmaceutical (TAK) said Monday it has received 510 (k) clearance for its HyHub and HyHub Duo PREMIUM Upgrade to read ...

Matcha mania is sweeping the world. The bright green Japanese tea can be found in everything from Starbucks' lattes in the UK ...

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1 30 Jun 2025 OSAKA, Japan & CAMBRIDGE, Mass.